Telomerase reverse transcriptase: A novel neuroprotective mechanism involved in neonatal hypoxic-ischemic brain injury

International Journal of Developmental Neuroscience

Volumn 29, Issue 8, 2011, Pages 867-872

  Li, Jiao ^a   Tang, Binzhi ^a   Qu, Yi ^a   Mu, Dezhi ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Apoptosis; Brain injury; Excitotoxicity; Neonatal hypoxic ischemic; Neurogenesis; Neuronal survival; Telomerase reverse transcriptase

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ANGIOGENESIS; APOPTOSIS; BRAIN DEVELOPMENT; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; DISEASE SEVERITY; ENZYME ACTIVATION; EXCITOTOXICITY; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; NEUROPROTECTIVE AGENTS; TELOMERASE;

RATTUS;

EID: 80455173933     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.07.010     Document Type: Review

References (57)

1. Ahmed S., Passos J.F., Birket M.J., Beckmann T., Brings S., Peters H., Birch-Machin M.A., von Zglinicki T., Saretzki G. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell Sci. 2008, 121:1046-1053.
2. Barks J.D., Liu Y.Q., Shangguan Y., Li J., Pfau J., Silverstein F.S. Impact of indolent inflammation on neonatal hypoxic-ischemic brain injury in mice. Int. J. Dev. Neurosci. 2008, 26:57-65.
3. Blackburn E.H. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 2005, 579:859-862.
4. Cheng A., Shin-ya K., Wan R., Tang S.C., Miura T., Tang H., Khatri R., Gleichman M., Ouyang X., Liu D., Park H.R., Chiang J.Y., Mattson M.P. Telomere protection mechanisms change during neurogenesis and neuronal maturation: newly generated neurons are hypersensitive to telomere and DNA damage. J. Neurosci. 2007, 27:3722-3733.
5. Choi K.C., Yoo D.S., Cho K.S., Huh P.W., Kim D.S., Park C.K. Effect of single growth factor and growth factor combinations on differentiation of neural stem cells. J. Korean Neurosurg. Soc. 2008, 44:375-381.
6. Chung H.K., Cheong C., Song J., Lee H.W. Extratelomeric functions of telomerase. Curr. Mol. Med. 2005, 5:233-241.
7. Davis B., Tang J., Zhang L., Mu D., Jiang X., Biran V., Vexler Z., Ferriero D.M. Role of vasodilator stimulated phosphoprotein in VEGF induced blood-brain barrier permeability in endothelial cell monolayers. Int. J. Dev. Neurosci. 2010, 28:423-428.
8. Del Bufalo D., Rizzo A., Trisciuoglio D., Cardinali G., Torrisi M.R., Zangemeister-Wittke U., Zupi G., Biroccio A. Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function. Cell Death Differ. 2005, 12:1429-1438.
9. Dicou E., Perez-Polo J.R. Bax-an emerging role in ectopic cell death. Int. J. Dev. Neurosci. 2009, 27:299-304.
10. Duan Z., Qu Y., Zhao F., Tang B., Li J., Mu D. Protective effect of conditioned medium from astrocytes transfected with telomerase reverse transcriptase on hypoxia-ischemia neurons. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2010, 24:1217-1223.
11. Dudognon C., Pendino F., Hillion J., Saumet A., Lanotte M., Segal-Bendirdjian E. Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance. Oncogene 2004, 23:7469-7474.
12. Ferriero D.M. Neonatal brain injury. N. Engl. J. Med. 2004, 351:1985-1995.
13. Fu W., Killen M., Culmsee C., Dhar S., Pandita T.K., Mattson M.P. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 2000, 14:3-15.
14. Fu W., Lu C., Mattson M.P. Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J. Neurosci. 2002, 22:10710-10719.
15. Fujiki T., Udono M., Kadooka K., Yamashita S., Miura T., Shirahata S., Katakura Y. Regulatory mechanisms of human and mouse telomerase reverse transcriptase gene transcription: distinct dependency on c-Myc. Cytotechnology 2010, 62:333-339.
16. Gao Y., Liang W., Hu X., Zhang W., Stetler R.A., Vosler P., Cao G., Chen J. Neuroprotection against hypoxic-ischemic brain injury by inhibiting the apoptotic protease activating factor-1 pathway. Stroke 2009, 41:166-172.
17. George J., Banik N.L., Ray S.K. Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma. Clin. Cancer Res. 2009, 15:7186-7195.
18. Geserick C., Tejera A., Gonzalez-Suarez E., Klatt P., Blasco M.A. Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene 2006, 25:4310-4319.
19. Haendeler J., Drose S., Buchner N., Jakob S., Altschmied J., Goy C., Spyridopoulos I., Zeiher A.M., Brandt U., Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler. Thromb. Vasc. Biol. 2009, 29:929-935.
20. Hagberg H., Mallard C., Rousset C.I., Xiaoyang W. Apoptotic mechanisms in the immature brain: involvement of mitochondria. J. Child Neurol. 2009, 24:1141-1146.
21. Honma T., Honmou O., Iihoshi S., Harada K., Houkin K., Hamada H., Kocsis J.D. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp. Neurol. 2006, 199:56-66.
22. Hossain M.A. Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection. Int. J. Dev. Neurosci. 2008, 26:93-101.
23. Iwai M., Cao G., Yin W., Stetler R.A., Liu J., Chen J. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke 2007, 38:2795-2803.
24. Jaskelioff M., Muller F.L., Paik J.H., Thomas E., Jiang S., Adams A.C., Sahin E., Kost-Alimova M., Protopopov A., Cadinanos J., Horner J.W., Maratos-Flier E., Depinho R.A. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469:102-106.
25. Jonakait G.M. The effects of maternal inflammation on neuronal development: possible mechanisms. Int. J. Dev. Neurosci. 2007, 25:415-425.
26. Kang H.J., Choi Y.S., Hong S.B., Kim K.W., Woo R.S., Won S.J., Kim E.J., Jeon H.K., Jo S.Y., Kim T.K., Bachoo R., Reynolds I.J., Gwag B.J., Lee H.W. Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity. J. Neurosci. 2004, 24:1280-1287.
27. Kawamura M., Nakajima W., Ishida A., Ohmura A., Miura S., Takada G. Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res. 2005, 1037:59-69.
28. Klapper W., Shin T., Mattson M.P. Differential regulation of telomerase activity and TERT expression during brain development in mice. J. Neurosci. Res. 2001, 64:252-260.
29. Kong L.P., Wu L.Z., Zhang J., Liao Y.P. Neuroprotectice effects of human telomerase reverse transcriptase on beta-amyloid fragment 25-35-treated human embryonic cortical neurons. Neural Regen. Res. 2009, 4:405-412. H.Q.W.
30. Kovalenko O.A., Caron M.J., Ulema P., Medrano C., Thomas A.P., Kimura M., Bonini M.G., Herbig U., Santos J.H. A mutant telomerase defective in nuclear-cytoplasmic shuttling fails to immortalize cells and is associated with mitochondrial dysfunction. Aging Cell 2010, 9:203-219.
31. Kumazaki T., Hiyama K., Takahashi T., Omatsu H., Tanimoto K., Noguchi T., Hiyama E., Mitsui Y., Nishiyama M. Differential gene expressions during immortalization of normal human fibroblasts and endothelial cells transfected with human telomerase reverse transcriptase gene. Int. J. Oncol. 2004, 24:1435-1442.
32. Kumral A., Ozer E., Yilmaz O., Akhisaroglu M., Gokmen N., Duman N., Ulukus C., Genc S., Ozkan H. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol. Neonate 2003, 83:224-228.
33. Lee J., Jo Y.S., Sung Y.H., Hwang I.K., Kim H., Kim S.Y., Yi S.S., Choi J.S., Sun W., Seong J.K., Lee H.W. Telomerase deficiency affects normal brain functions in mice. Neurochem. Res. 2010, 35:211-218.
34. Lee J., Sung Y.H., Cheong C., Choi Y.S., Jeon H.K., Sun W., Hahn W.C., Ishikawa F., Lee H.W. TERT promotes cellular and organismal survival independently of telomerase activity. Oncogene 2008, 27:3754-3760.
35. Li L., Xiong Y., Qu Y., Mao M., Mu W., Wang H., Mu D. The requirement of extracellular signal-related protein kinase pathway in the activation of hypoxia inducible factor 1 alpha in the developing rat brain after hypoxia-ischemia. Acta Neuropathol. 2008, 115:297-303.
36. Lu C., Fu W., Mattson M.P. Telomerase protects developing neurons against DNA damage-induced cell death. Brain Res. Dev. Brain Res. 2001, 131:167-171.
37. Massard C., Zermati Y., Pauleau A.L., Larochette N., Metivier D., Sabatier L., Kroemer G., Soria J.C. hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene 2006, 25:4505-4514.
38. Matsumori Y., Northington F.J., Hong S.M., Kayama T., Sheldon R.A., Vexler Z.S., Ferriero D.M., Weinstein P.R., Liu J. Reduction of caspase-8 and -9 cleavage is associated with increased c-FLIP and increased binding of Apaf-1 and Hsp70 after neonatal hypoxic/ischemic injury in mice overexpressing Hsp70. Stroke 2006, 37:507-512.
39. Mattson M.P., Fu W., Zhang P. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech. Ageing Dev. 2001, 122:659-671.
40. Metka Derganc, Osredkar D. Hypoxic-ischemic brain injury in the neonatal period-current concepts, novel diagnostic approaches and neuroprotective strategies. Zdrav. Vestn. 2008, 77:51-58.
41. Murasawa S., Llevadot J., Silver M., Isner J.M., Losordo D.W., Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 2002, 106:1133-1139.
42. Northington F.J., Graham E.M., Martin L.J. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited?. Brain Res. Brain Res. Rev. 2005, 50:244-257.
43. Park W.S., Sung D.K., Kang S., Koo S.H., Kim Y.J., Lee J.H., Chang Y.S., Lee M. Neuroprotective effect of cycloheximide on hypoxic-ischemic brain injury in neonatal rats. J. Korean Med. Sci. 2006, 21:337-341.
44. Pfennig F., Kind B., Zieschang F., Busch M., Gutzeit H.O. TERT expression and telomerase activity in gonads and somatic cells of the Japanese medaka (Oryzias latipes). Dev. Growth Differ. 2008, 50:131-141.
45. Roy N.S., Nakano T., Keyoung H.M., Windrem M., Rashbaum W.K., Alonso M.L., Kang J., Peng W., Carpenter M.K., Lin J., Nedergaard M., Goldman S.A. Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord. Nat. Biotechnol. 2004, 22:297-305.
46. Smith L.L., Coller H.A., Roberts J.M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 2003, 5:474-479.
47. Song M.S., Jeong J.S., Cho K.S., Lee S.W. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme. Exp. Mol. Med. 2007, 39:722-732.
48. Sung Y.H., Choi Y.S., Cheong C., Lee H.W. The pleiotropy of telomerase against cell death. Mol. Cells 2005, 19:303-309.
49. Wang Z., Xu J., Geng X., Zhang W. Analysis of DNA methylation status of the promoter of human telomerase reverse transcriptase in gastric carcinogenesis. Arch. Med. Res. 2010, 41:1-6.
50. Weis S.N., Schunck R.V., Pettenuzzo L.F., Krolow R., Matte C., Manfredini V., do Carmo R.P.M., Vargas C.R., Dalmaz C., Wyse A.T., Netto C.A. Early biochemical effects after unilateral hypoxia-ischemia in the immature rat brain. Int. J. Dev. Neurosci. 2011, 29:115-120.
51. Wyatt H.D., West S.C., Beattie T.L. InTERTpreting telomerase structure and function. Nucleic Acids Res. 2010, 38:5609-5622.
52. Zaccagnini G., Gaetano C., Della Pietra L., Nanni S., Grasselli A., Mangoni A., Benvenuto R., Fabrizi M., Truffa S., Germani A., Moretti F., Pontecorvi A., Sacchi A., Bacchetti S., Capogrossi M.C., Farsetti A. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J. Biol. Chem. 2005, 280:14790-14798.
53. Zanelli S.A. Hypoxic-ischemic Encephalopathy 2009, http://emedicine.medscape.com/article/973501-overview.
54. Zhang B., Chen L., Swartz K.R., Bruemmer D., Eum S.Y., Huang W., Seelbach M., Choi Y.J., Hennig B., Toborek M. Deficiency of telomerase activity aggravates the blood-brain barrier disruption and neuroinflammatory responses in a model of experimental stroke. J. Neurosci. Res. 2010, 88:2859-2868.
55. Zhang P., Chan S.L., Fu W., Mendoza M., Mattson M.P. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J. 2003, 17:767-769.
56. Zhang R.G., Zhao J.J., Yang L.Q., Yang S.M., Wang R.Q., Chen W.S., Peng G.Y., Fang D.C. RNA interference-mediated hTERT inhibition enhances TRAIL-induced apoptosis in resistant hepatocellular carcinoma cells. Oncol. Rep. 2010, 23:1013-1019.
57. Zhao F., Qu Y., Tang B., Mao M., Mu D. Telomerase reverse transcriptase expression and cell apoptosis during hypoxia ischemia brain damage in neonatal rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2010, 24:588-593.